US Global Health Committee report on heart disease burden: prioritize noncommunicable diseases

236ac40e-facf-42a7-a874-5087f18a9678articleimage.jpg

01 Dec 2017 --- The US must prioritize its health resources toward detecting and treating noncommunicable diseases, such as cardiovascular disease, while maintaining and expanding prevention and eradication of infectious diseases on a global scale. This is according to a report modified from US global health recommendations from the National Academies of Sciences, Engineering and Medicine (previously the Institute of Medicine) published in the Journal of the American College of Cardiology.

Appropriate global health strategies have the potential to not only save lives, but also contribute to worldwide economic prosperity and growth, the American College of Cardiology notes. It goes on to say that the US has been a leader in promoting global health through focused programs on AIDS, malaria, tuberculosis and other infectious diseases, and as a result of these programs and sanitation and prevention improvements, the disease burden globally has shifted from infectious diseases to noncommunicable diseases.

In this report, the Committee on Global Health and the Future of the United States was tasked with identifying current global health priorities and making recommendations to the US government and other stakeholders to increase responsiveness, coordination and efficiency in addressing global health needs. It developed recommendations that, according to the paper, “would deliver a strong global health strategy and maintain the role of the United States as a leader in global health.”

The committee first outlined four priority areas for action: 1) achieving global security, 2) maintaining a sustained response to the continuous threats of communicable diseases, 3) saving and improving the lives of women and children, and 4) promoting cardiovascular health and preventing cancer.

“These NASEM recommendations and this manuscript are among the most important efforts of my career, because if they are adopted by the US government, they have the potential to enact true change for global health,” says corresponding author Valentin Fuster, M.D., Ph.D., from Mt. Sinai Medical Center in New York. “The next step for the committee is to present these recommendations to the US Senate and to President Donald J. Trump.”

Three cross-cutting areas were further developed to maximize the returns on investment, achieve better health outcomes and use funding more effectively: 1) catalyze innovation through accelerated development of medical products and integrated digital health infrastructure, 2) employ more nimble and flexible financing mechanisms to leverage new partners and funders in global health, and 3) maintain US status and influence as a world leader in global health while adhering to evidence-based science and economics, measurement and accountability.

Specifically, in this report, the committee focuses on the detection and management of cardiovascular disease and offers a roadmap for achieving better outcomes in preventing and treating heart disease, including through screening, accelerated drug development, digital health and smart financing strategies.

Heart disease’s status as a serious problem worldwide was made clear when a recent study from the European Society of Cardiology pointed out that a decline in deaths from heart attack and stroke in high-income countries such as the UK could be threatened by rising rates of obesity and diabetes. The study also found that the UK is lagging behind many lower-income countries in some aspects of heart disease prevention.

RELATED ARTICLES
Homepicture

Fermentalg reports on Q1 revenue as US expansion begins

20 Apr 2018 Fermentalg, a French supplier of microalgae for ...

Homepicture

CJ CheilJedang to expand L-Arginine and L-Citrulline production in Indonesia

13 Apr 2018 8 --- CJ CheilJedang is making plans to build a ...

Homepicture

Clinical merger: Novartis acquires AveXis for US$8.7bn, expands in gene therapy

09 Apr 2018 Novartis has entered into an agreement and plan ...

Homepicture

GSK to take full ownership of Novartis stake in Consumer Healthcare Business for US$13bn

27 Mar 2018 GlaxoSmithKline (GSK) has reached an agreement ...

Homepicture

Probi signs agreement with pharma company Cilag on probiotic OTC product

23 Mar 2018 Probi has signed a long-term agreement with ...